Skip to main content
MSF logo
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
Medicines shouldn’t be a luxury Take action
Get involved
Our campaigns

Latest Press Releases

Latest Press Releases

Helena gets a chance to talk to her son Moses who is an Ebola confirmed patient. A MSF health promoter supports this difficult moment for the young mother as she is too overwhelmed with what to say. The health promoter advises her to say positive things such as "I am waiting here outside for you“ or "I am thinking of you non Stop“. Photograph by Martin Zinggl
Press release
Press release |
13 November 2014
Intellectual property and trade

First trials for Ebola treatments to start at MSF sites in December

5 min
MSF doctor Christoph Höhn performs an eye test on 16-year-old patient Shahnoza in her family home. Shahnoza started MDR-TB treatment in October 2012 but was later diagnosed with XDR-TB. Since January 2013, she is on the right drug regimen, but she will ne Photograph by Wendy Marijnissen
Press release
Press release |
30 October 2014
Tuberculosis

MSF sounds alarm on practices and policies dangerously out of step with what’s needed to contain the global drug-resistant TB crisis

MSF141573 Photograph by Julien Rey/MSF
Press release
Press release |
24 October 2014
Tropical & neglected diseases

Ebola: MSF urges immediate action on vaccines and treatments for frontline workers

Press release
Press release |
09 October 2014
Tuberculosis

“I can also serve as an inspiration”

Ubaldo Mendoza, 18, has initiated Chagas treatment in San Pedro Pochutlas health facility. Photograph by Consuelo Pagaza
Press release
Press release |
01 October 2014
Tropical & neglected diseases
Mexico

Chagas diagnosis and treatment a reality in Oaxaca state

4 min
Press release |
26 September 2014
Intellectual property and trade
India

MSF urges Prime Minister Modi to resist US political pressure to restrict global access to medicines

3 min
Press release |
10 September 2014
Intellectual property and trade
Viet Nam

MSF quote on TPP negotiations in Hanoi, Vietnam

2 min
Press release |
28 July 2014
Hepatitis C Intellectual property and trade

On World Hepatitis Day, organisations call on SA government: protect infants with HepB jab at birth & reduce patent barriers to HepB therapies

5 min
  • Load More
Navigate
  • About MSF Access
  • Contact us
  • Get involved
  • Our work
  • Resources
  • Search
Get updates
  • Sign up for our newsletter
  • Privacy & data protection information
Contact

MSF Access
Médecins Sans Frontières
140 Route de Ferney
1202 Geneva, Switzerland
Phone:+41 22 849 8484
E-mail: [email protected]

Follow us

  • X
  • Facebook
  • YouTube
  • Medium
Medicines Shouldn't Be A Luxury